These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10945510)

  • 21. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
    D'Hooge D; Lehert P; Clement DL
    Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J; Guidicelli H; Glanddier G; Mosnier M
    Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and tolerance of long-term naftidrofuryl treatment of patients with senile dementia. Controlled study versus placebo].
    Cucinotta D; Dall'Asta D; Benaglia F; Ciotti G; Nicora M; Passeri M
    G Clin Med; 1987 Apr; 68(4):211-7. PubMed ID: 3301493
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of naftidrofuryl in patients with moderate senile dementia.
    Saldmann F; Funel A; Jacquet P
    Curr Med Res Opin; 1991; 12(6):379-89. PubMed ID: 2044398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
    Brodie NH
    Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
    [No Abstract]   [Full Text] [Related]  

  • 31. Naftidrofuryl in the treatment of subacute stroke.
    Capon A; Lehert P; Opsomer L
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S62-6. PubMed ID: 1369722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
    Grossmann W; Standl A; May U
    Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
    [No Abstract]   [Full Text] [Related]  

  • 34. Nimodipine in subcortical vascular dementia trial.
    Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind study in the treatment of normal tension glaucoma with naftidrofuryl.
    Mermoud A; Faggioni R; Van Melle GD
    Ophthalmologica; 1990; 201(3):145-51. PubMed ID: 2089356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg.
    Adhoute G; Bacourt F; Barral M; Cardon JM; Chevalier JM; Cuny A; Gillet M; Juhan C; Leguay G; Marion J
    Angiology; 1986 Mar; 37(3 Pt 1):160-7. PubMed ID: 3518547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of the tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin].
    González-González JA; Lozano R
    Rev Neurol; 2000 Apr 16-30; 30(8):719-28. PubMed ID: 10893735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of naftidrofuryl in multimorbidity in geriatric patients].
    Platt D; Mühlberg W; Rieck W; Horn HJ; Schmitt-Rüth R
    Z Gerontol; 1984; 17(5):246-50. PubMed ID: 6523980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and tolerance of aniracetam in elderly patients with primary or secondary mental deterioration].
    Canonico V; Forgione L; Paoletti C; Casini A; Colonna CV; Bertini M; Acito R; Rengo F
    Riv Neurol; 1991; 61(3):92-6. PubMed ID: 1767242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
    Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.